Abstract:ObjectiveThe objective of this study was to investigate the telomerase activity of phytohemagglutinin-activated lymphocytes from patients with Alzheimer disease. BackgroundThere is impairment of immune function in patients with Alzheimer disease, and the perturbation of immune system is involved the pathogenesis of Alzheimer disease. However, the mechanism of the impairment is unclear so far. MethodsWe analyzed telomerase activities of phytohemagglutinin-activated lymphocytes from 187 cases of patients with Alzheimer disease, 53 cases of patients with vascular dementia, and 80 cases of age-matched healthy controls, respectively. Telomerase activity was measured using the telomeric repeat amplification protocol–based telomerase polymerase chain reaction enzyme-linked immunosorbent assay. We also detected the proliferation activity of peripheral blood mononuclear cells from 10 cases of patients with Alzheimer disease or 10 cases of age-matched healthy controls by [3H] thymidine incorporation. ResultsTelomerase activity of phytohemagglutinin-activated lymphocytes in Alzheimer disease patients was significantly elevated compared with healthy controls (P < 0.01) and vascular dementia patients (P < 0.01), respectively. There was significant statistical correlation between the telomerase activities of lymphocytes and the degree of dementia in Alzheimer disease patients. The proliferation activity of peripheral blood mononuclear cells to phytohemagglutinin was significantly decreased in Alzheimer disease patients compared with age-matched healthy controls (P < 0.01). ConclusionsOur data suggest that there could be an accelerated telomere dysfunction in lymphocytes of Alzheimer disease patients, which induces the increase of telomerase activity and the decrease of proliferation activity of lymphocytes, and subsequently results in the impairment of immune function in Alzheimer disease patients.

Study of the role of leukocyte telomere length-related lncRNA NBR2 in Alzheimer's disease

Exploring the Causal Pathway from Telomere Length to Alzheimer’s Disease: an Update Mendelian Randomization Study

Telomere Dysfunction of Lymphocytes in Patients with Alzheimer Disease.

Leukocyte Telomere Length and Amyotrophic Lateral Sclerosis: a Mendelian Randomization Study

Telomere Shortening in Alzheimer's Disease Patients.

Exploring the Causal Relationship Between Telomere Biology and Alzheimer’s Disease

Meta-analysis of the Connection Between Alzheimer Disease and Telomeres

The Association between Long Non-Coding RNAs and Alzheimer's Disease

Leucocyte telomere length, brain volume and risk of dementia: a prospective cohort study

Long Non-coding RNA: Insight Into Mechanisms of Alzheimer's Disease

An updated analysis of the association between CD2-associated protein gene rs9349407 polymorphism and Alzheimer's disease in Chinese population

Integration of single-cell sequencing with machine learning and Mendelian randomization analysis identifies the NAP1L1 gene as a predictive biomarker for Alzheimer's disease

Integrative analysis of single-nucleus RNA sequencing and Mendelian randomization to explore novel risk genes for Alzheimer's disease

A causal relationship between leukocyte telomere length and multiple sclerosis: A Mendelian randomization study

The Association Between Leukocyte Telomere Length And Cognitive Performance Among The American Elderly

Identification of Key Long Non-Coding RNAs in the Pathology of Alzheimer’s Disease and Their Functions Based on Genome-Wide Associations Study, Microarray, and RNA-seq Data

Telomere length and brain imaging phenotypes in UK Biobank

Epigenome-wide association study of leukocyte telomere length.

Leukocyte Telomere Length is Associated with Advanced Age-Related Macular Degeneration in the Han Chinese Population

Telomerase reverse transcriptase and neurodegenerative diseases

Identification of Alzheimer's Disease–associated Long Noncoding RNAs